T1	Participants 121 134	rectal cancer
T2	Participants 296 333	preoperative staging of rectal cancer
T3	Participants 366 427	patients with rectal cancer from October 2007 to October 2008
T4	Participants 470 528	two groups: MSCT and SAA combined group: both MSCT and SAA
T5	Participants 608 665	only MSCT was performed preoperatively for tumor staging.
T6	Participants 837 894	225 cases with rectal cancer were enrolled in this study.
T7	Participants 906 974	110 cases in MSCT and SAA combined group and 115 cases in MSCT group
T8	Participants 529 606	combinative assessment were performed for preoperative evaluation; MSCT group
